FDA Investigator Matthew R Noonan

Matthew R Noonan has inspections in 3 countries as of 19 Oct 2023. Matthew R Noonan has collaborated with a combinined 3502 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
153
Last Inspection Date:
19 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Israel, Canada
Co-Investigator(s):
Alan D Centi, Albert A Salvador, Alexandra B Pitkin, Alfred Puglia, Alison N Correll, Anastasia G Lolas, Anastasia I Offordile, Anastasia I Onuorah, Anastasia M Shields, Anita R Michael, Ann Marie Karnick, Anna Lazar, Anthony A Charity, Audrey Thereset Uy, Beichner, Brandon J Brookens, Brian D Young, Brian M Palermo, Brian R Yaun, Brian S Keefer, Calvin W Edwards, Cara M Minelli, CDR Michael J Mero, Chamberlain, Charles M Edwards, Christina K Theodorou, Colleen M Damon, Craig D Zagata, Crayton Lee, Crystal A Harlan, Cynthia A Palmer, Cynthia White, Daniel J Deciero, Daniel J Min, Daniel W Johnson, Dauksism, David A Oluwo, David A Schwartz, David J Hafner, Deborah G Haney Cozzone, Deborah H Cozzone, Deborah J Parris, Debra J Bennett, Debra L Pagano, Denise M Digiulio, Derek S Dealy, Donald W Myrick, Donyel M Jones, Dougherty, Dr. Gerald E Poly, Edward D Mcdonald, Edwin L Hobbs, Eric S Myskowski, Erik A Bungo, Erika M Wilkerson, Frank W Perrella, Gayle S Lawson, George Pyramides, Gerald W Kopp, Gess, Giovanni A Vigilante, H Ljamilla Selby, Hala L Selby, Hala Lj Whetstone, Heriberto Negron Rivera, Howard B Rabinovitch, Ivy E Sweeney, Jacob M Dyer, Jaison J Eapen, James C Illuminati, James C Maclaughlin, James M Mason, James P Mcevoy, Javier E Santos, Jean Blackston Hill, Jean Blackstone Hill, Jeannie R Mayberry, Jeen S Min, Joanne Heim, Joanne M Hajoway, John A Gonzalez, Joseph Brady, Joseph L Despins, PhD, Joseph S Fanelli, Joseph T Dougherty, Joshua C Schafer, Judith A Paterson, Julianne C Mccullough, Jullianne C Mccullough, Junho Pak, Justin B Holder, Karthik B Iyer, Karyn M Campbell, Kendra L Brooks, Kim G Campbell, Kimberly A Dux, Kish Bolden, Kristen D Evans, Kristina Conroy, Kristina J Donohue, Kristina L Conroy, Kristina Mjoyce Pittman, Kyle D Covill, Kyle S Hobson, LCDR Margaret E Digennaro, LCDR Susan E Polifko, Lillian C Hsu, Linda K Cline, Linda M Hoover, Linda M Ross, Lisa B Orr, Lisa M Bellows, Lori A Rose, LT John M Mastalski, LTJG Lauren N Shade, Luella J Rossi, Luis A Dasta, Magda M Karlsen, Marc A Jackson, Jr, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marea K Harmon, Margaret Faulkner, Maria A Reed, Martha Sullivan Myrick, Mary Ddavis Lopez, Mary E Storch, Mastalskij, Matther R Noonan, Matthew L Doyle, Matthew R Nooman, Matthew R Noona, Maureen A Wentzel, Maureen C Melvin, Melissa M Dauksis, Melissa M Schafer, Meredith L Sheridan, Michael A Taylor, Michael Gurbarg, Michael J Nerz, Michael L Casner, Michael R Goga, Michael Rosner, Michele Gottshall, Michele M Falchek, Mike M Rashti, Myrick, Namita Kothary, Nancy M Lazzari, Nicholas J Morici, Nikhil Thakur, Nikisha M Bolden, Pamela M Tremarki, Paul L Bellamy, Peter R Lenahan, Philip F Istafanos, DMV, MS, Prabhu P Raju, Princess R Campbell, Qin Xu, Rachael O Oyewole, Raffi B Papazian, Ramanda C Gregory, Raymond L Cheung, Robert B Shibuya, MD, Robert G Ruff, Robert J Maffei, Robin P Mathew, Ronald A Stokes, Ronald T Colucci, Rose Ljean Mary, Russell P Vandermark, Sam Pepe, Sarah K Lemin, Scott T Ballard, Sean D Duke, Seng Ching Hwang, Sharon K Thoma, PharmD, Sharon Mills, State Agency, Stephanie Mangigian, MS/OSH, RN, Stephen J Koniers, Steven E Kane, Sullivanm, Susan F Laska, MS, Tammy L Chavis, Tania E Vizcaino, Teigan M Mule, Tekalign Wondimu, Temar Q Williams, Thomas E Friel, Tiffani D Wilson, Todd J Maushart, Tonya O Corbin, Travers, Van Cliff, Vlada Matusovsky, Whitney S Reynolds, William C Brenneman, Xinyi Hui, Yessika Mashinski, Yvonne C Mcknight, Yvonne C Wood

Matthew R Noonan's Documents

Publish Date Document Type Title
August, 2011 EIR OraWell USA - EIR, 2011-08-05
July, 2013 FDA 483 Accupac, LLC - Form 483, 2013-07-19
January, 2013 FDA 483 Brown MD, Raymond - Form 483, 2013-01-29
January, 2013 EIR Brown MD, Raymond - EIR, 2013-01-29
April, 2016 FDA 483 IVD, LLC - Form 483, 2016-04-22
May, 2009 FDA 483 Accupac, LLC - Form 483, 2009-06-26
July, 2012 FDA 483 Auxilium Pharmaceuticals, LLC - Form 483, 2012-07-06
July, 2012 EIR Auxilium Pharmaceuticals, LLC - EIR, 2012-07-06
April, 2012 FDA 483 Tri-Med Medical Supplies, Inc - Form 483, 2012-04-06
February, 2015 EIR Laurence H. Belkoff D.O. - EIR, 2015-02-12
January, 2012 FDA 483 Frontida BioPharm, LLC - Form 483, 2012-01-27
September, 2013 FDA 483 IVD, LLC - Form 483, 2013-09-30
March, 2013 FDA 483 Protica, Inc. - Form 483, 2013-03-26
August, 2014 EIR JBS Souderton, Inc. dba MOPAC - EIR, 2014-08-06
February, 2016 FDA 483 Janssen Therapeutics, A Division of Janssen Products, LP, Janssen R&D, LLC - Form 483, 2016-02-25
March, 2012 FDA 483 Abbey Color Incorporated - Form 483, 2012-03-23
September, 2011 EIR JBS Souderton, Inc. dba MOPAC - EIR, 2011-09-13
July, 2009 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2009-07-24
September, 2014 FDA 483 High Chemical Company, Div of National Generic Distributors - Form 483, 2014-09-05
August, 2011 FDA 483 Axcentria Pharmaceuticals LLC - Form 483, 2011-08-31
August, 2013 EIR JBS Souderton, Inc. dba MOPAC - EIR, 2013-08-20
July, 2016 FDA 483 Response STI Pharma LLC - Form 483R, 2016-08-08
February, 2015 FDA 483 Laurence H. Belkoff D.O. - Form 483, 2015-02-12
February, 2010 FDA 483 Lannett Company, Inc. - Form 483, 2010-02-09
April, 2010 FDA 483 Johnson & Johnson Consumer Inc. - Form 483, 2010-04-30
July, 2011 EIR Johnson & Johnson Consumer Inc. - EIR, 2011-07-22
December, 2011 FDA 483 Sigmapharm Laboratories, LLC - Form 483, 2011-12-22
April, 2013 EIR Air Liquide Electronics U.S. LP - EIR, 2013-04-17
March, 2010 FDA 483 Northtec LLC - Form 483, 2010-03-29
September, 2015 FDA 483 Acuity Specialty Products, Inc dba AFCO US - Form 483, 2015-09-11
October, 2014 EIR Johnson & Johnson Consumer Products Company - EIR, 2014-10-03
August, 2014 FDA 483 JBS Souderton, Inc. dba MOPAC - Form 483, 2014-08-06
October, 2014 FDA 483 Response Johnson & Johnson Consumer Products Company - Form 483R, 2014-10-23
October, 2011 FDA 483 Protica, Inc. - Form 483, 2011-10-06
February, 2014 FDA 483 Fine Grinding Corp - Form 483, 2014-02-25
February, 2010 FDA 483 Lannett Company, Inc. - Form 483, 2010-02-09
May, 2013 FDA 483 Northtec LLC - Form 483, 2013-05-10
November, 2010 FDA 483 PADC 1 - Form 483, 2010-11-30
April, 2016 EIR IVD, LLC - EIR, 2016-04-22
August, 2013 FDA 483 JBS Souderton, Inc. dba MOPAC - Form 483, 2013-08-20
November, 2009 FDA 483 Medical Components, Inc dba MedComp - Form 483, 2009-11-09
April, 2013 FDA 483 Air Liquide Electronics U.S. LP - Form 483, 2013-04-17
September, 2013 EIR IVD, LLC - EIR, 2013-09-30
August, 2012 FDA 483 Protica, Inc. - Form 483, 2012-08-27
September, 2011 FDA 483 JBS Souderton, Inc. dba MOPAC - Form 483, 2011-09-13
September, 2012 EIR CSL Behring LLC - EIR, 2012-09-14
July, 2016 FDA 483 STI Pharma LLC - Form 483, 2016-07-21
October, 2014 FDA 483 Johnson & Johnson Consumer Products Company - Form 483, 2014-10-03

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more